$104.98
-4.64-4.23%
At close: -
$105.71
0.730.70%
After Hours: 4:01 PM EDT
Comments
Loading...
Blueprint Medicines (BPMC) Forecast
NewsEarningsBlueprint Medicines (BPMC) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestBlueprint Medicines (NASDAQ:BPMC) Stock Quotes, Forecast and News Summary
Blueprint Medicines Stock (NASDAQ: BPMC) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Blueprint Medicines (BPMC) stock?
You can purchase shares of Blueprint Medicines (NASDAQ:BPMC) through any online brokerage.
Who are Blueprint Medicines (BPMC) competitors?
Other companies in Blueprint Medicines’s space includes: Legend Biotech (NASDAQ:LEGN), Ultragenyx Pharmaceutical (NASDAQ:RARE), Avidity Biosciences (NASDAQ:RNA), Sarepta Therapeutics (NASDAQ:SRPT) and Exact Sciences (NASDAQ:EXAS).
What is the forecast, or price target, for Blueprint Medicines (BPMC) stock?
Blueprint Medicines has a consensus price target of $116.43.
What is the current price for Blueprint Medicines (BPMC)?
The stock price for Blueprint Medicines (NASDAQ: BPMC) is $105.71 last updated February 7, 2025 at 4:01 PM EST.
Does Blueprint Medicines (BPMC) pay a dividend?
There are no upcoming dividends for Blueprint Medicines.
When is Blueprint Medicines (NASDAQ:BPMC) reporting earnings?
Blueprint Medicines’s Q1 earnings are confirmed for Thursday, May 1, 2025.
Is Blueprint Medicines (BPMC) going to split?
There is no upcoming split for Blueprint Medicines.
What sector and industry does Blueprint Medicines (BPMC) operate in?
Blueprint Medicines is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.